Anthera Pharmaceuticals Inc:企業のM&A・事業提携・投資動向

◆英語タイトル:Anthera Pharmaceuticals Inc - Mergers & Acquisitions (M&A), Partnerships & Alliances and Investment Report
◆商品コード:DATA904C1967
◆発行会社(調査会社):MarketLine
◆発行日:2018年7月
◆ページ数:82
◆レポート言語:英語
◆レポート形式:PDF
◆納品方法:Eメール
◆対象地域:アメリカ
◆産業分野:製薬・医療
◆販売価格オプション(消費税別)
Single User(1名様閲覧用)USD350 ⇒換算¥51,800見積依頼/購入/質問フォーム
Site License(同一事業所内共有可)USD700 ⇒換算¥103,600見積依頼/購入/質問フォーム
Enterprisewide License(複数事業所内共有可)USD1,050 ⇒換算¥155,400見積依頼/購入/質問フォーム
販売価格オプションの説明はこちらでご利用ガイドはこちらでご確認いただけます。
※お支払金額は「換算金額(日本円)+消費税+配送料(Eメール納品は無料)」です。
※本体価格が¥30,000未満のレポートにつきましては、ハンドリングチャージ¥5,000が別途かかります。
※Eメールによる納品の場合、通常ご注文当日〜2日以内に納品致します。
※レポート納品後、納品日+5日以内に請求書を発行し、お客様宛に郵送しますので、請求書発行日より2ヶ月以内に振込をお願いします。
※為替レートは適宜修正・更新しております。リアルタイム更新ではありません。
※弊社H&Iグローバルリサーチ株式会社はMarketLine社の日本における正規販売代理店です。同社発行の企業調査レポートに関するお問い合わせは弊社までお願い致します。
MarketLine社の概要はこちらでご確認いただけます。



【レポートの概要】

Anthera Pharmaceuticals Inc – Mergers & Acquisitions (M&A), Partnerships & Alliances and Investment Report
Summary

Marketline’s Anthera Pharmaceuticals Inc Mergers & Acquisitions (M&A), Partnerships & Alliances and Investments report includes business description, detailed reports on mergers and acquisitions (M&A), divestments, capital raisings, venture capital investments, ownership and partnership transactions undertaken by Anthera Pharmaceuticals Inc since January2007.

Synopsis

Marketline’s Company Mergers & Acquisitions (M&A), Partnerships & Alliances and Investments reports offer a comprehensive breakdown of the organic and inorganic growth activity undertaken by an organization to sustain its competitive advantage.

Key Highlights

This report includes Anthera Pharmaceuticals Inc’s contact information and business summary, tables, graphs, a list of partners and targets, a breakdown of financial and legal advisors, deal types, top deals by deal value, detailed deal reports, and descriptions and contact details of the partner, target, investor, and vendor firms, where disclosed.

The profile also includes detailed deal reports for all M&A, private equity, public offering, venture financing, partnership and divestment transactions undertaken by Anthera Pharmaceuticals Inc. These deal reports contain information about target company financials, sources of financing, method of payment, deal values, and advisors for various parties, where disclosed.

Scope

- Provides intelligence on Anthera Pharmaceuticals Inc’s M&A, strategic partnerships and alliances, capital raising and private equity transactions.
- Detailed reports of various financial transactions undertaken by Anthera Pharmaceuticals Inc and its subsidiaries since 2007.
- Information about key financial and legal advisors for Anthera Pharmaceuticals Inc’s financial deals transactions.
- Financial deals tables and charts covering deal value and volumes trend, deal types and geography-based deal activity.

Reasons to buy

- Access comprehensive financial deals data along with charts and graph covering M&A, private equity, and partnerships and alliances.
- Form an independent opinion about Anthera Pharmaceuticals Inc’s growth strategies through the organic and inorganic activities undertaken since 2007.
- Track your competitors’ business structure and growth strategies.

【レポートの目次】

Table of Contents
COMPANY OVERVIEW AND KEY FACTS 2
TABLE OF CONTENTS 5
LIST OF TABLES 6
LIST OF FIGURES 6
TARGETS AND PARTNERS 7
MERGERS & ACQUISITIONS 8
Mergers and Acquisitions – Overview 8
Mergers and Acquisitions – Deal reports 9
PARTNERSHIP 12
Partnership – Overview 12
Partnership – Deal reports 13
CAPITAL RAISING 32
Capital Raising – Overview 32
Capital Raising – Deal reports 33
APPENDIX 72
Contact Us 72
About MarketLine Financial Deals Database 72
Deal Definition and Methodology 74
About MarketLine 81

List of Tables
Table 1: Anthera Pharmaceuticals M&A volume and value trend (2014-YTD2018)
Table 2: Anthera Pharmaceuticals M&A activity by geography (2014-YTD2018)
Table 3: Anthera Pharmaceuticals partnership volume and value trend (2014-YTD2018)
Table 4: Anthera Pharmaceuticals partnership trend by key deal type (2014-YTD2018)
Table 5: Anthera Pharmaceuticals capital raising volume and value trend (2014-YTD2018)
Table 6: Anthera Pharmaceuticals capital raising by deal type (2014-YTD2018)

List of Figures
Figure 1: Anthera Pharmaceuticals M&A volume and value trend (2014-YTD2018)
Figure 2: Anthera Pharmaceuticals M&A activity by geography (2014-YTD2018)
Figure 3: Anthera Pharmaceuticals partnership volume and value trend (2014-YTD2018)
Figure 4: Anthera Pharmaceuticals partnership trend by key deal type (2014-YTD2018)
Figure 5: Anthera Pharmaceuticals capital raising volume and value trend (2014-YTD2018)
Figure 6: Anthera Pharmaceuticals capital raising by deal type (2014-YTD2018)

★海外企業調査レポート[Anthera Pharmaceuticals Inc:企業のM&A・事業提携・投資動向]についてメールでお問い合わせはこちら

■おすすめ企業レポート■
  • Suzlon Energy Ltd (SUZLON):企業の財務・戦略的SWOT分析
    Suzlon Energy Ltd (SUZLON) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weaknesse …
  • Diversicare Healthcare Services Inc (DVCR):製薬・医療:M&Aディール及び事業提携情報
    Summary Diversicare Healthcare Services Inc (Diversicare), formerly Advocat Inc is a healthcare service provider that offers post acute care services and short term rehabilitation and long-term care services to nursing home patients. The company’s services include life steps rehabilitation program, …
  • Grill Concepts, Inc.:企業の戦略・SWOT・財務情報
    Grill Concepts, Inc. - Strategy, SWOT and Corporate Finance Report Summary Grill Concepts, Inc. - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings …
  • Embotelladora Andina SA (ANDINA-B):企業の財務・戦略的SWOT分析
    Embotelladora Andina SA (ANDINA-B) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and w …
  • Barry Callebaut AG:企業の戦略・SWOT・財務情報
    Barry Callebaut AG - Strategy, SWOT and Corporate Finance Report Summary Barry Callebaut AG - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings and …
  • Lotus Bakeries NV:企業の戦略・SWOT・財務情報
    Lotus Bakeries NV - Strategy, SWOT and Corporate Finance Report Summary Lotus Bakeries NV - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings and c …
  • Charcot-Marie-Tooth Association:製薬・医療:M&Aディール及び事業提携情報
    Summary Charcot-Marie-Tooth Association (CMTA) is a healthcare service provider that offers healthcare services to patients suffering from charcot marie tooth disease. The association provides services such as public education, patient support, and research promotion. It offers services such as orth …
  • OrthoAccel Technologies Inc:医療機器:M&Aディール及び事業提携情報
    Summary OrthoAccel Technologies Inc (AcceleDent) is a medical device company that manufactures, develops, and markets orthodontic treatment and dental care products. The company’s products include acceledent aura is an accelerated tooth movement device designed for faster orthodontic treatment based …
  • Carnival Group International Holdings Ltd:企業のM&A・事業提携・投資動向
    Carnival Group International Holdings Ltd - Mergers & Acquisitions (M&A), Partnerships & Alliances and Investment Report Summary Marketline's Carnival Group International Holdings Ltd Mergers & Acquisitions (M&A), Partnerships & Alliances and Investments report includes business description, detaile …
  • CIBC Wealth Management:企業の戦略・SWOT・財務分析
    CIBC Wealth Management - Strategy, SWOT and Corporate Finance Report Summary CIBC Wealth Management - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offer …
  • C.H. Robinson Worldwide, Inc.:企業の戦略・SWOT・財務情報
    C.H. Robinson Worldwide, Inc. - Strategy, SWOT and Corporate Finance Report Summary C.H. Robinson Worldwide, Inc. - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and …
  • RentPath, LLC:企業の戦略・SWOT・財務分析
    RentPath, LLC - Strategy, SWOT and Corporate Finance Report Summary RentPath, LLC - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings and corporate …
  • Xbrane Biopharma AB (XBRANE):製薬・医療:M&Aディール及び事業提携情報
    Summary Xbrane Biopharma AB (Xbrane), formerly Xbrane Bioscience AB is a biopharmaceutical company that develops and manufactures complex generic products. The company's product portfolio includes biosimilars and long acting injectables developed for people suffering from critical diseases. It combi …
  • China Energy Conservation and Environmental Protection Group-エネルギー分野:企業M&A・提携分析
    Summary China Energy Conservation and Environmental Protection Group (CECEP) is a clean technology company that offers energy conservation, emission reduction and environment protection services. The company provides clean energy, energy saving, environmental protection, integrated services and reso …
  • EnQuest PLC (ENQ):企業の財務・戦略的SWOT分析
    Summary EnQuest Plc (EnQuest) is an independent oil and gas exploration and production company. The company’s assets include producing oil fields, portfolio of discoveries, and new developments. Its oil and gas exploration assets are located in the UK North Sea and also have presence in oil basins o …
  • Matrai Eromu ZRt:企業の戦略的SWOT分析
    Matrai Eromu ZRt - Strategic SWOT Analysis Review provides a comprehensive insight into the company’s history, corporate strategy, business structure and operations. The report contains a detailed SWOT analysis, information on the company’s key employees, key competitors and major products and servi …
  • Penn Virginia Corp (PVAC):石油・ガス:M&Aディール及び事業提携情報
    Summary Penn Virginia Corp (Penn Virginia) is an independent oil and gas company. It explores, develops, and produces crude oil, Natural gas liquids (NGL), and natural gas. The company’s operations consist primarily of drilling unconventional horizontal development wells and operating producing well …
  • National Comprehensive Cancer Network-製薬・医療分野:企業M&A・提携分析
    Summary National Comprehensive Cancer Network (NCCN) is a contract research organization that offers clinical services. The organization offers research and medical information to help patients and health professionals related to cancer care. It provides subscriptions and products which include NCCN …
  • Bajaj Allianz General Insurance Company Limited:企業の戦略・SWOT・財務情報
    Bajaj Allianz General Insurance Company Limited - Strategy, SWOT and Corporate Finance Report Summary Bajaj Allianz General Insurance Company Limited - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, o …
  • UbiQ Bio BV:製薬・医療:M&Aディール及び事業提携情報
    Summary UbiQ Bio BV (UbiQ) is a biotechnology company that develops and commercializes ubiquitinated peptides and assays that enables drug discovery in Ubiquitin field. The company provides products such as ubiquitin-proteasome system, high throughput screening assay reagents and ubiquitinated polyp …

◆H&Iグローバルリサーチ株式会社のお客様(例)◆